Outcomes of Transvenous Lead Extraction in Patients With End‐Stage Renal Disease
Journal of Cardiovascular Electrophysiology · 2026
DOI: 10.1111/jce.70232 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Birju R Rao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Device Removal, Defibrillators, Implantable, Pacemaker, Artificial. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Background
Patients with end‐stage renal disease (ESRD) on hemodialysis are at increased risk for bacteremia, which may necessitate transvenous lead extraction (TLE) if a cardiac implantable electronic device (CIED) is present. Most data on outcomes of TLE in ESRD come from small, single‐center studies.
Methods
The National Inpatient Sample database was analyzed to identify hospitalizations where patients underwent TLE between 2016 and 2021. Baseline demographics, comorbidities, and outcomes were stratified by history of ESRD.
Results
We identified 98 115 weighted hospitalizations where patients underwent TLE, of which 5005 (5%) had a history of ESRD. Patients with ESRD were younger and had a higher prevalence of comorbidities including congestive heart failure, diabetes, hypertension, and liver dysfunction. Compared to those without ESRD, in‐hospital mortality was significantly higher in patients with ESRD undergoing TLE (10.4% vs. 2.5%, p < 0.001). The incidence of vascular complications (including superior vena cava perforation) and cardiogenic shock was also higher in patients with ESRD, as was the length of stay and total hospitalization cost. Even after adjustment for baseline differences, in‐hospital mortality after TLE remained significantly higher in patients with ESRD (adjusted odds ratio [ORs] 2.1, 95% confidence interval 1.6−2.7).
Conclusion
In a nationally representative cohort, unadjusted in‐hospital mortality among patients with ESRD undergoing TLE is over 10%, and even after adjustment for covariates, patients with ESRD were more than twice as likely to die in the hospital compared to non‐ESRD patients undergoing TLE. The increased availability of CIEDs without transvenous hardware may mitigate some of the long‐term burden of device implantation in patients with ESRD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.
Zitieren
APA
Rao, B. R., Jain, V., Leal, M. A., Bhatia, N. K., El Chami, M. F., & Merchant, F. M. (2026). Outcomes of Transvenous Lead Extraction in Patients With End‐Stage Renal Disease. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70232
Vancouver
Rao BR, Jain V, Leal MA, Bhatia NK, El Chami MF, Merchant FM. Outcomes of Transvenous Lead Extraction in Patients With End‐Stage Renal Disease. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70232
BibTeX
@article{Rao2026,
author = {Rao, Birju R and Jain, Vardhmaan and Leal, Miguel A and Bhatia, Neal K and El Chami, Mikhael F and Merchant, Faisal M},
title = {Outcomes of Transvenous Lead Extraction in Patients With End‐Stage Renal Disease},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2026},
doi = {10.1111/jce.70232}
}
EUVIMED